复发性多合体炎患者的临床表现和治疗:一个多中心观察队列研究
Roger Yang1, Rennie L Rhee2, Kaitlin A Quinn3
1University of Pennsylvania, Philadelphia, and University of Montreal, Montreal, Canada.
ACR open rheumatology
|May 20, 2025
概括
复发性多合体炎 (RP) 是一种罕见的疾病,具有多种症状和显著的器官损伤. 目前的治疗方法,通常涉及葡萄糖皮质激素 (GCs),缺乏标准化,突出需要临床试验和指导方针.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 罕见疾病 罕见疾病
背景情况:
- 复发性多合体炎 (RP) 是一种罕见的多系统性自身免疫性疾病,其特征是软骨组织的炎症.
- 疾病的异质性和缺乏确定的治疗方案对患者管理构成重大挑战.
研究的目的:
- 描述复发性多重合体炎患者队列中的临床表现和器官损伤.
- 分析不同的治疗方法及其与疾病结果的关联.
主要方法:
- 一项观察性多中心队列研究,涉及诊断为RP的成年患者.
- 数据收集包括临床表现,器官损伤和药物史.
- 根据药物类别,治疗被分为三组:单独使用或不使用葡萄糖皮质激素 (GCs),使用或不使用GCs的非生物免疫抑制剂 (IS),以及使用或不使用其他治疗的JAK抑制剂 (JAKis) 或生物IS药物.
主要成果:
- 该研究包括195名RP患者,主要是女性 (86%) 和白人 (89%),平均年龄为49岁.
- 所有患者都表现出耳朵,鼻子或呼吸道的干扰,83%的人有肌肉骨的表现. 临床表现的中位数为11.
- 在41%的患者中观察到器官损伤. 与其他组相比,接受JAKis或生物IS药物治疗的患者 (3组) 更有可能经历器官损伤,关节炎和小肠狭窄症.
结论:
- 复发性多重合体炎给人带来了相当大的临床负担,并导致严重的器官损伤.
- 虽然GCs通常使用,但其他免疫抑制疗法的应用有所不同.
- 缺乏标准化的治疗方法强调了进一步进行临床试验和制定基于证据的RP治疗指南的迫切需要.
更多相关视频
相关概念视频
COPD: Pathogenesis and Clinical Features
223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223
Gastroesophageal Reflux Disease II: Clinical Features and Management
44
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
44
Inflammatory Bowel Disease II: Crohn's Disease
154
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
154
Chronic Bowel Disorders: Introduction
375
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
375
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K


